Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000213659 | SCV000276489 | likely benign | Hereditary cancer-predisposing syndrome | 2015-06-22 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Counsyl | RCV000412168 | SCV000489457 | likely benign | Lynch syndrome 1 | 2016-10-11 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000559419 | SCV000625426 | likely benign | Hereditary nonpolyposis colorectal neoplasms | 2023-11-11 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000213659 | SCV000904005 | likely benign | Hereditary cancer-predisposing syndrome | 2017-08-17 | criteria provided, single submitter | clinical testing | |
Myriad Genetics, |
RCV000412168 | SCV004018399 | benign | Lynch syndrome 1 | 2023-03-22 | criteria provided, single submitter | clinical testing | This variant is considered benign. This variant is a silent/synonymous amino acid change and it is not expected to impact splicing. |
Ce |
RCV003421971 | SCV004146067 | likely benign | not provided | 2022-10-01 | criteria provided, single submitter | clinical testing | MSH2: BP4, BP7 |
All of Us Research Program, |
RCV003997174 | SCV004830277 | likely benign | Lynch syndrome | 2023-06-28 | criteria provided, single submitter | clinical testing |